Adient Q3 2024 Sales $3.716B Miss $3.826B Estimate
Portfolio Pulse from Benzinga Newsdesk
Adient (NYSE:ADNT) reported Q3 2024 sales of $3.716 billion, missing the analyst consensus estimate of $3.826 billion by 2.87%. This represents an 8.36% decrease from the same period last year.
August 06, 2024 | 10:53 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Adient reported Q3 2024 sales of $3.716 billion, missing the analyst consensus estimate of $3.826 billion by 2.87%. This is an 8.36% decrease from the same period last year, indicating potential challenges in revenue generation.
The miss on sales estimates and the year-over-year decline in revenue suggest potential difficulties in Adient's business operations, likely leading to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100